Dolphin Medical Services Reports ₹1.68 Lakhs Net Profit in Q3FY26
Dolphin Medical Services Limited reported improved profitability in Q3FY26 with net profit rising to ₹1.68 lakhs from ₹0.69 lakhs year-on-year, despite revenue declining to ₹20.61 lakhs from ₹24.30 lakhs. For nine months FY26, the company achieved ₹5.41 lakhs net profit compared to ₹3.62 lakhs in the previous year. Effective cost management, particularly a reduction in other expenses from ₹18.63 lakhs to ₹9.10 lakhs, contributed to enhanced profitability. The results were approved by the Board on February 6, 2026.
*this image is generated using AI for illustrative purposes only.
Dolphin Medical Services Limited has reported its unaudited financial results for the third quarter of FY26 ended December 31, 2025, showing improved profitability despite a decline in revenue. The Hyderabad-based medical services company achieved a net profit of ₹1.68 lakhs compared to ₹0.69 lakhs in the corresponding quarter of the previous year, representing a significant improvement in bottom-line performance.
Financial Performance Overview
The company's quarterly financial performance presents a mixed picture with revenue contraction but enhanced profitability:
| Metric | Q3FY26 | Q3FY25 | Change |
|---|---|---|---|
| Revenue from Operations | ₹20.61 lakhs | ₹24.30 lakhs | -15.19% |
| Total Revenue | ₹21.53 lakhs | ₹25.22 lakhs | -14.63% |
| Net Profit | ₹1.68 lakhs | ₹0.69 lakhs | +143.48% |
| Basic EPS | ₹0.01 | ₹0.01 | No change |
Revenue from operations declined to ₹20.61 lakhs in Q3FY26 from ₹24.30 lakhs in Q3FY25. Including other income of ₹0.92 lakhs, total revenue stood at ₹21.53 lakhs compared to ₹25.22 lakhs in the previous year quarter.
Nine-Month Performance Analysis
For the nine-month period ended December 31, 2025, Dolphin Medical Services demonstrated strong profit growth:
| Parameter | 9M FY26 | 9M FY25 | Variance |
|---|---|---|---|
| Revenue from Operations | ₹55.81 lakhs | ₹63.59 lakhs | -12.24% |
| Total Revenue | ₹58.57 lakhs | ₹66.35 lakhs | -11.72% |
| Net Profit | ₹5.41 lakhs | ₹3.62 lakhs | +49.45% |
| Total Expenses | ₹53.16 lakhs | ₹62.73 lakhs | -15.26% |
The company achieved a net profit of ₹5.41 lakhs for the nine-month period compared to ₹3.62 lakhs in the corresponding period of FY25, despite revenue declining from ₹63.59 lakhs to ₹55.81 lakhs.
Cost Management and Operational Efficiency
Dolphin Medical Services demonstrated effective cost control measures during the quarter. Total expenses decreased to ₹19.85 lakhs in Q3FY26 from ₹24.53 lakhs in Q3FY25. Key expense categories showed the following trends:
- Employee benefit expense: Increased to ₹4.90 lakhs from ₹2.10 lakhs
- Other expenses: Significantly reduced to ₹9.10 lakhs from ₹18.63 lakhs
- Depreciation and amortisation: Rose to ₹2.80 lakhs from ₹1.16 lakhs
- Cost of materials consumed: Increased to ₹2.81 lakhs from ₹2.41 lakhs
The substantial reduction in other expenses from ₹18.63 lakhs to ₹9.10 lakhs was a key factor contributing to improved profitability despite lower revenue.
Corporate Governance and Shareholding Structure
The company maintains a stable shareholding structure with paid-up equity share capital of ₹1,509.99 lakhs, consisting of shares with a face value of ₹10.00 each. Public shareholding stands at 1,11,07,651 shares, representing 73.56% of total share capital. Promoter and promoter group hold 39,92,301 shares (26.44% of total share capital), with no pledged or encumbered shares.
During Q3FY26, the company reported no investor complaints, maintaining its clean record with nil pending complaints at the beginning and end of the quarter. The financial results were reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on February 6, 2026, which commenced at 1:30 PM and concluded at 2:30 PM.
15
